Insigneo Advisory Services’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $203K | Sell |
387
-24
| -6% | -$12.6K | 0.02% | 567 |
|
|
2025
Q1 | $261K | Sell |
411
-9
| -2% | -$5.71K | 0.03% | 448 |
|
|
2024
Q4 | $299K | Sell |
420
-416
| -50% | -$296K | 0.03% | 419 |
|
|
2024
Q3 | $878K | Sell |
836
-223
| -21% | -$234K | 0.09% | 195 |
|
|
2024
Q2 | $1.13M | Buy |
1,059
+107
| +11% | +$115K | 0.13% | 155 |
|
|
2024
Q1 | $916K | Buy |
952
+250
| +36% | +$241K | 0.11% | 175 |
|
|
2023
Q4 | $617K | Buy |
702
+305
| +77% | +$268K | 0.09% | 206 |
|
|
2023
Q3 | $327K | Buy |
397
+42
| +12% | +$34.6K | 0.07% | 269 |
|
|
2023
Q2 | $255K | Buy |
+355
| New | +$255K | 0.05% | 314 |
|